Gabelli Funds LLC Decreases Stock Position in Amedisys, Inc. (NASDAQ:AMED)

Gabelli Funds LLC cut its stake in shares of Amedisys, Inc. (NASDAQ:AMED) by 0.3% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 223,402 shares of the health services provider’s stock after selling 723 shares during the quarter. Gabelli Funds LLC’s holdings in Amedisys were worth $20,589,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors also recently bought and sold shares of the company. Banque Cantonale Vaudoise bought a new position in shares of Amedisys during the first quarter valued at about $60,000. Covestor Ltd lifted its holdings in Amedisys by 134.2% in the 1st quarter. Covestor Ltd now owns 780 shares of the health services provider’s stock worth $72,000 after buying an additional 447 shares during the period. Cetera Trust Company N.A purchased a new stake in Amedisys in the 4th quarter worth approximately $215,000. CWM LLC grew its position in shares of Amedisys by 40.4% in the 4th quarter. CWM LLC now owns 2,629 shares of the health services provider’s stock worth $250,000 after buying an additional 757 shares during the last quarter. Finally, Mesirow Institutional Investment Management Inc. increased its stake in shares of Amedisys by 9.9% during the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 2,844 shares of the health services provider’s stock valued at $270,000 after buying an additional 257 shares during the period. 94.36% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages recently commented on AMED. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $101.00 price target on shares of Amedisys in a research note on Thursday. William Blair lowered shares of Amedisys from an “outperform” rating to a “market perform” rating in a report on Monday, July 1st. Finally, StockNews.com raised shares of Amedisys from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $100.67.

Amedisys Stock Up 0.5 %

Shares of NASDAQ AMED traded up $0.50 during mid-day trading on Friday, hitting $98.25. 1,410,227 shares of the stock traded hands, compared to its average volume of 494,022. The stock has a fifty day moving average price of $94.89 and a 200-day moving average price of $93.82. The company has a debt-to-equity ratio of 0.31, a quick ratio of 1.09 and a current ratio of 1.09. The company has a market cap of $3.21 billion, a price-to-earnings ratio of -153.51, a PEG ratio of 2.37 and a beta of 0.79. Amedisys, Inc. has a 52 week low of $89.55 and a 52 week high of $98.95.

Amedisys (NASDAQ:AMED) last released its earnings results on Wednesday, April 24th. The health services provider reported $1.03 earnings per share for the quarter, topping analysts’ consensus estimates of $1.02 by $0.01. Amedisys had a net margin of 4.02% and a return on equity of 12.56%. The firm had revenue of $571.41 million for the quarter, compared to the consensus estimate of $565.38 million. During the same period in the prior year, the firm earned $1.00 EPS. The company’s revenue was up 2.7% compared to the same quarter last year. Research analysts anticipate that Amedisys, Inc. will post 4.62 EPS for the current year.

Amedisys Profile

Amedisys, Inc, together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; nursing services, rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients.